Matches in SemOpenAlex for { <https://semopenalex.org/work/W4320730607> ?p ?o ?g. }
- W4320730607 endingPage "332.e11" @default.
- W4320730607 startingPage "332.e1" @default.
- W4320730607 abstract "The alkylating agent busulfan is commonly used as conditioning in allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia (AML). However, a consensus has not yet been reached regarding the optimal busulfan dose in cord blood transplantation (CBT). Therefore, we conducted this large nationwide cohort study to retrospectively analyze the outcomes of CBT in patients with AML receiving busulfan at intermediate (6.4 mg/kg i.v.; BU2) or higher (12.8 mg/kg i.v.; BU4) doses within a fludarabine/i.v. busulfan (FLU/BU) regimen. Among 475 patients who underwent their first CBT following FLU/BU conditioning between 2007 and 2018, 162 received BU2 and 313 received BU4. Multivariate analysis identified BU4 as a significant factor for longer disease-free survival (hazard ratio [HR], .85; 95% confidence interval [CI], .75 to .97; P = .014) and a lower relapse rate (HR, .84; 95% CI, .72 to .98; P = .030). No significant differences were observed in non-relapse mortality between BU4 and BU2 (HR, 1.05; 95% CI, .88-1.26; P = .57). Subgroup analyses showed that BU4 provided significant benefits for patients who underwent transplantation while not in complete remission (CR) and those age <60 years. Our present results suggest that higher busulfan doses are preferable in patients undergoing CBT, particularly those not in CR and younger patients." @default.
- W4320730607 created "2023-02-15" @default.
- W4320730607 creator A5001196940 @default.
- W4320730607 creator A5005548083 @default.
- W4320730607 creator A5007469704 @default.
- W4320730607 creator A5010422580 @default.
- W4320730607 creator A5015382183 @default.
- W4320730607 creator A5015566446 @default.
- W4320730607 creator A5015601730 @default.
- W4320730607 creator A5020985742 @default.
- W4320730607 creator A5023036531 @default.
- W4320730607 creator A5024134742 @default.
- W4320730607 creator A5025340212 @default.
- W4320730607 creator A5033486602 @default.
- W4320730607 creator A5038408710 @default.
- W4320730607 creator A5046954326 @default.
- W4320730607 creator A5046989635 @default.
- W4320730607 creator A5049556471 @default.
- W4320730607 creator A5052615919 @default.
- W4320730607 creator A5054078877 @default.
- W4320730607 creator A5065276140 @default.
- W4320730607 creator A5069791653 @default.
- W4320730607 creator A5089002578 @default.
- W4320730607 date "2023-05-01" @default.
- W4320730607 modified "2023-09-30" @default.
- W4320730607 title "Advantages of Higher Busulfan Dose Intensity in Fludarabine-Combined Conditioning for Patients with Acute Myeloid Leukemia Undergoing Cord Blood Transplantation" @default.
- W4320730607 cites W1274344746 @default.
- W4320730607 cites W1795844187 @default.
- W4320730607 cites W1965979673 @default.
- W4320730607 cites W1973617793 @default.
- W4320730607 cites W1975771741 @default.
- W4320730607 cites W1984001484 @default.
- W4320730607 cites W1990247501 @default.
- W4320730607 cites W1992011065 @default.
- W4320730607 cites W2021993787 @default.
- W4320730607 cites W2038981426 @default.
- W4320730607 cites W2048365016 @default.
- W4320730607 cites W2057094192 @default.
- W4320730607 cites W2059706629 @default.
- W4320730607 cites W2066816406 @default.
- W4320730607 cites W2067480394 @default.
- W4320730607 cites W2073140442 @default.
- W4320730607 cites W2074636573 @default.
- W4320730607 cites W2074959262 @default.
- W4320730607 cites W2088844333 @default.
- W4320730607 cites W2092777433 @default.
- W4320730607 cites W2094729406 @default.
- W4320730607 cites W2121960517 @default.
- W4320730607 cites W2130680567 @default.
- W4320730607 cites W2136016420 @default.
- W4320730607 cites W2142467765 @default.
- W4320730607 cites W2167517686 @default.
- W4320730607 cites W2532562305 @default.
- W4320730607 cites W2564896331 @default.
- W4320730607 cites W2740686538 @default.
- W4320730607 cites W2753831100 @default.
- W4320730607 cites W3041644330 @default.
- W4320730607 cites W3131246988 @default.
- W4320730607 cites W3177056913 @default.
- W4320730607 cites W3201206697 @default.
- W4320730607 cites W4237287329 @default.
- W4320730607 doi "https://doi.org/10.1016/j.jtct.2023.02.004" @default.
- W4320730607 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36796517" @default.
- W4320730607 hasPublicationYear "2023" @default.
- W4320730607 type Work @default.
- W4320730607 citedByCount "0" @default.
- W4320730607 crossrefType "journal-article" @default.
- W4320730607 hasAuthorship W4320730607A5001196940 @default.
- W4320730607 hasAuthorship W4320730607A5005548083 @default.
- W4320730607 hasAuthorship W4320730607A5007469704 @default.
- W4320730607 hasAuthorship W4320730607A5010422580 @default.
- W4320730607 hasAuthorship W4320730607A5015382183 @default.
- W4320730607 hasAuthorship W4320730607A5015566446 @default.
- W4320730607 hasAuthorship W4320730607A5015601730 @default.
- W4320730607 hasAuthorship W4320730607A5020985742 @default.
- W4320730607 hasAuthorship W4320730607A5023036531 @default.
- W4320730607 hasAuthorship W4320730607A5024134742 @default.
- W4320730607 hasAuthorship W4320730607A5025340212 @default.
- W4320730607 hasAuthorship W4320730607A5033486602 @default.
- W4320730607 hasAuthorship W4320730607A5038408710 @default.
- W4320730607 hasAuthorship W4320730607A5046954326 @default.
- W4320730607 hasAuthorship W4320730607A5046989635 @default.
- W4320730607 hasAuthorship W4320730607A5049556471 @default.
- W4320730607 hasAuthorship W4320730607A5052615919 @default.
- W4320730607 hasAuthorship W4320730607A5054078877 @default.
- W4320730607 hasAuthorship W4320730607A5065276140 @default.
- W4320730607 hasAuthorship W4320730607A5069791653 @default.
- W4320730607 hasAuthorship W4320730607A5089002578 @default.
- W4320730607 hasConcept C126322002 @default.
- W4320730607 hasConcept C141071460 @default.
- W4320730607 hasConcept C143998085 @default.
- W4320730607 hasConcept C207103383 @default.
- W4320730607 hasConcept C2776694085 @default.
- W4320730607 hasConcept C2776755627 @default.
- W4320730607 hasConcept C2777408962 @default.
- W4320730607 hasConcept C2778729363 @default.
- W4320730607 hasConcept C2779263901 @default.
- W4320730607 hasConcept C2780611847 @default.